Prismic Pharmaceuticals, Inc. — Form D/A

Prismic Pharmaceuticals, Inc. of SCOTTSDALE, AZ, a company, filed a Form D amendment with the SEC on 2013-02-20. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2013-02-20
• Form: D/A
• Accession: 0001557310-13-000001
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $1.2M
• Amount sold: $1.2M
• Minimum investment: $5K
• Investors: 22
• Date of first sale: 2012-10-04
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-183500

Issuer

• Name: Prismic Pharmaceuticals, Inc.
• CIK: 0001557310
• Entity type: Corporation
• Jurisdiction: ARIZONA
• Incorporated: 2011
• Address: 8283 N. HAYDEN ROAD, SCOTTSDALE, AZ, 85258
• Phone: 480-422-1810

Officers, directors & promoters (9)

Other filings by this issuer (2)

More

• CIK 1557310 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search